moxifloxacin has been researched along with clebopride in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (clebopride) | Trials (clebopride) | Recent Studies (post-2010) (clebopride) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 116 | 17 | 11 |
| Protein | Taxonomy | moxifloxacin (IC50) | clebopride (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 0.89 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.017 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.6026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
1 other study(ies) available for moxifloxacin and clebopride
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |